View Future GrowthThis company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsPowerUp Acquisition 過去の業績過去 基準チェック /06PowerUp Acquisitionの収益は年平均-20.7%で減少しているが、Capital Markets業界はgrowingで6.3%年平均の収益となった。主要情報-20.74%収益成長率-267.15%EPS成長率Capital Markets 業界の成長10.26%収益成長率n/a株主資本利益率n/aネット・マージンn/a前回の決算情報30 Sep 2024最近の業績更新更新なしすべての更新を表示Recent updatesお知らせ • Aug 16PowerUp Acquisition Corp. announced delayed 10-Q filingOn 08/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Aug 01Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction.Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction on July 31, 2024. The transaction is subject to various contingencies and conditions, including the Aspire Biopharma's requisite investor consents, third party consents and regulatory review, including from the Securities and Exchange Commission and a national securities exchange. Dykema Gossett, PLLC serves as legal counsel to PowerUp Acquisition Corp. Sichenzia Ross Ference Carmel LLP serves as legal counsel to Aspire BioPharma, Inc.お知らせ • May 17PowerUp Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.New Risk • Mar 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-US$322k). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$99.4m market cap).Board Change • Dec 31High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Mayur Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Dec 29Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million.Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million on December 26, 2023. The merger would result in Visiox becoming a publicly traded company on the Nasdaq Capital Market. Upon closing, the combined company will be named Visiox Holdings, Inc. with its common stock and warrants expected to be listed on Nasdaq under the ticker symbols VSXP and VSXPW, respectively. Upon the closing of the Transaction, Visiox will continue to be led by current Chief Executive Officer, Ryan Bleeks. The Merger Agreement contains customary conditions to Closing, including the following mutual conditions of the parties (unless waived): (i) approval of the shareholders of PowerUp and Visiox of the Transaction and the other matters requiring shareholder approval; (ii) approvals of any required governmental authorities and completion of any antitrust expiration periods; (iii) receipt of specified third party consents; (iv) no law or order preventing the Transaction; (v) the Registration Statement having been declared effective by the SEC; (vi) the satisfaction of the $5,000,001 minimum net tangible asset test by PowerUp; (vii) approval from Nasdaq for the listing of the shares of PowerUp’s common stock to be issued in connection with the Transaction; and (viii) reconstitution of the Post-Closing Board as contemplated under the Merger Agreement. Kate Bechen of Dykema Gossett PLLC serves as legal counsel to PowerUp Acquisition Corp. and David Mannheim of Nelson Mullins Riley & Scarborough LLP serves as legal counsel to Visiox Pharmaceuticals, Inc.New Risk • Nov 10New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$63k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$63k). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$98.1m market cap).New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (9.4% average weekly change).お知らせ • Aug 25+ 3 more updatesPowerup Acquisition Corp. Announces Board ChangesPowerUp Acquisition Corp. announced that on the Effective Date, in connection with the Purchase Agreement, (i) Bruce Hack, Jack Tretton, Peter Blacklow, Julie Uhrman, and Kyle Campbell (the Resigning Directors") tendered their resignations as members of the board of directors of the Company (the Board"), (ii) Jack Tretton, Michael Olson, and Gabriel Schillinger resigned as officers of the Company, (iii) Surendra Ajjarapu, Michael L. Peterson, Donald G. Fell, Mayur Doshi, and Avinash Wadhwani were appointed as members of the Board (each, a New Director"), (iv) Surendra Ajjarapu was appointed Chairman of the Board, and (v) Surendra Ajjarapu and Howard Doss were appointed as the Company's Chief Executive Officer and Chief Financial Officer, respectively (each, a New Officer"). Suren Ajjarapu (age: 53) has served as Chairman of the Board, Chief Executive Officer and Secretary of TrXADE HEALTH, INC and its predecessor company since July 2010. He is also currently a director of Oceantech Acquisition I Corp., traded on Nasdaq under the symbol OTECU", serves as Chairman of the board of directors of Kernel Group Holdings Inc. and Semper Paratus Acquisition Corporation, a special purpose acquisition company. Beginning in 2021, Mr. Ajjarapu served as Chief Executive Officer and Chairman of Aesther Healthcare Acquisition Corp., a special purpose acquisition company that consummated its initial business combination in February 2023. Mr. Ajjarapu is currently serving as a director of the merged company, Ocean Biomedical Inc. Since March 2018, Mr. Ajjarapu has served as Executive Chairman of the Board of Kano Energy Corp., a company involved in the development of renewable natural gas sites in the United States. Mr. Ajjarapu was a Founder and served as Chief Executive Officer and Chairman of the Board of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest of the United States, from March 2009 to December 2012. Mr. Ajjarapu was also a Founder, President and Director of Aemetis Inc. and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis Inc., from January 2006 to March 2009. Mr. Ajjarapu was Co-Founder, Chief Operations Officer, and Director of Global Information Technology Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India. Mr. Ajjarapu graduated from South Dakota State University with a M.S. in Environmental Engineering, and from the University of South Florida with an M.B.A., specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University. Michael Peterson (age: 61) commenced serving as President, Chief Executive Officer and as a member of the Board of Directors of Lafayette Energy Corp. in April 2022. Beginning in September 2021, Mr. Peterson served as a member of the Board of Directors, Audit Committee (Chair), Compensation Committee and Nominating and Corporate Governance Committee of Aesther Healthcare Acquisition Corp. Mr. Peterson is currently serving as a director of the merged company, Ocean Biomedical Inc. In addition, Mr. Peterson commenced serving as an independent director of Oceantech Acquisition I Corp., in March 2023, began serving as an independent director of KRNL in December 2022 and as an independent director of Semper Paratus Acquisition Corporation in June 2023. Mr. Peterson has served as the president of Nevo Motors Inc. since December 2020, which was established to commercialize a range extender generator technology for the heavy-duty electric vehicle market but is currently non-operational. Since May 2022, Mr. Peterson has served as a member of the Board of Directors and as the Chairperson of the Audit Committee of Trio Petroleum Corp., an oil and gas exploration and development company which is in the process of going public. Since February 2021, Mr. Peterson has served on the board of directors and as the Chairman of the Audit Committee of Indonesia Energy Corporation Limited (NYSE American: INDO). Mr. Peterson previously served as the president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan from June 2018 to June 2021. Mr. Peterson served as an independent member of the Board of Directors of TRxADE HEALTH, INC from August 2016 to May 2021. Mr. Peterson served as the Chief Executive Officer of PEDEVCO Corp.Mr. Peterson served as Chief Financial Officer of PEDEVCO between July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (PEDEVCO's predecessor) from July 2012 to October 2014, and as PEDEVCO's President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a director (from May 2006 to July 2012) of Aemetis Inc. and as Chairman and Chief Executive Officer of Nevo Energy Inc. From 2005 to 2006, Mr. Peterson served as a managing partner of American Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high-net-worth investors. From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs & Co. in a variety of positions and roles, including as a Vice President. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham Young University.お知らせ • May 20PowerUp Acquisition Corp. Appoints Kyle Campbell, as Class Iii Director, Effective May 16, 2022Effective May 16, 2022, the board of directors of PowerUp Acquisition Corp. appointed Kyle Campbell, as a Class III director of the Company. In connection with his appointment to the Board, Mr. Campbell has been appointed to the Audit Committee of the Board. Since May 2021, Mr. Campbell has served as a senior analyst at Greenhaven Road Capital.Seeking Alpha • Apr 22PowerUp Acquisition Purses Video Gaming And Metaverse TargetsPowerUp Acquisition went public recently, garnering approximately $288 million in an IPO. The SPAC seeks to merge with a target in the video gaming and related industries. While management's video gaming background is impressive, they lack a SPAC track record, so I'm on Hold for PWUP in the near term.収支内訳PowerUp Acquisition の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史NasdaqGM:PWUP 収益、費用、利益 ( )USD Millions日付収益収益G+A経費研究開発費30 Sep 240-42030 Jun 240-34031 Mar 240-14031 Dec 23041030 Sep 23071030 Jun 23081031 Mar 23061031 Dec 22031030 Sep 22011030 Jun 22000031 Mar 220000質の高い収益: PWUPは現在利益が出ていません。利益率の向上: PWUPは現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: PWUPの過去 5 年間の前年比収益成長率がプラスであったかどうかを判断するにはデータが不十分です。成長の加速: PWUPの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: PWUPは利益が出ていないため、過去 1 年間の収益成長をCapital Markets業界 ( 37.2% ) と比較することは困難です。株主資本利益率高いROE: PWUPの負債は資産を上回っているため、自己資本利益率を計算することは困難です。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YDiversified-financials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2025/02/19 09:27終値2025/02/14 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋PowerUp Acquisition Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Aug 16PowerUp Acquisition Corp. announced delayed 10-Q filingOn 08/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Aug 01Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction.Aspire BioPharma, Inc. signed a non-binding letter of intent to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction on July 31, 2024. The transaction is subject to various contingencies and conditions, including the Aspire Biopharma's requisite investor consents, third party consents and regulatory review, including from the Securities and Exchange Commission and a national securities exchange. Dykema Gossett, PLLC serves as legal counsel to PowerUp Acquisition Corp. Sichenzia Ross Ference Carmel LLP serves as legal counsel to Aspire BioPharma, Inc.
お知らせ • May 17PowerUp Acquisition Corp. announced delayed 10-Q filingOn 05/15/2024, PowerUp Acquisition Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
New Risk • Mar 13New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Negative equity (-US$322k). Revenue is less than US$1m. Minor Risk Market cap is less than US$100m (US$99.4m market cap).
Board Change • Dec 31High number of new and inexperienced directorsThere are 5 new directors who have joined the board in the last 3 years. The company's board is composed of: 5 new directors. No experienced directors. No highly experienced directors. Independent Director Mayur Doshi is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Dec 29Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million.Visiox Pharmaceuticals, Inc. executed definitive agreement to acquire PowerUp Acquisition Corp. (NasdaqGM:PWUP) in a reverse merger transaction for $0.3 million on December 26, 2023. The merger would result in Visiox becoming a publicly traded company on the Nasdaq Capital Market. Upon closing, the combined company will be named Visiox Holdings, Inc. with its common stock and warrants expected to be listed on Nasdaq under the ticker symbols VSXP and VSXPW, respectively. Upon the closing of the Transaction, Visiox will continue to be led by current Chief Executive Officer, Ryan Bleeks. The Merger Agreement contains customary conditions to Closing, including the following mutual conditions of the parties (unless waived): (i) approval of the shareholders of PowerUp and Visiox of the Transaction and the other matters requiring shareholder approval; (ii) approvals of any required governmental authorities and completion of any antitrust expiration periods; (iii) receipt of specified third party consents; (iv) no law or order preventing the Transaction; (v) the Registration Statement having been declared effective by the SEC; (vi) the satisfaction of the $5,000,001 minimum net tangible asset test by PowerUp; (vii) approval from Nasdaq for the listing of the shares of PowerUp’s common stock to be issued in connection with the Transaction; and (viii) reconstitution of the Post-Closing Board as contemplated under the Merger Agreement. Kate Bechen of Dykema Gossett PLLC serves as legal counsel to PowerUp Acquisition Corp. and David Mannheim of Nelson Mullins Riley & Scarborough LLP serves as legal counsel to Visiox Pharmaceuticals, Inc.
New Risk • Nov 10New major risk - Negative shareholders equityThe company has negative equity. Total equity: -US$63k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Negative equity (-US$63k). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$98.1m market cap).
New Risk • Nov 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 9.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Share price has been volatile over the past 3 months (9.4% average weekly change).
お知らせ • Aug 25+ 3 more updatesPowerup Acquisition Corp. Announces Board ChangesPowerUp Acquisition Corp. announced that on the Effective Date, in connection with the Purchase Agreement, (i) Bruce Hack, Jack Tretton, Peter Blacklow, Julie Uhrman, and Kyle Campbell (the Resigning Directors") tendered their resignations as members of the board of directors of the Company (the Board"), (ii) Jack Tretton, Michael Olson, and Gabriel Schillinger resigned as officers of the Company, (iii) Surendra Ajjarapu, Michael L. Peterson, Donald G. Fell, Mayur Doshi, and Avinash Wadhwani were appointed as members of the Board (each, a New Director"), (iv) Surendra Ajjarapu was appointed Chairman of the Board, and (v) Surendra Ajjarapu and Howard Doss were appointed as the Company's Chief Executive Officer and Chief Financial Officer, respectively (each, a New Officer"). Suren Ajjarapu (age: 53) has served as Chairman of the Board, Chief Executive Officer and Secretary of TrXADE HEALTH, INC and its predecessor company since July 2010. He is also currently a director of Oceantech Acquisition I Corp., traded on Nasdaq under the symbol OTECU", serves as Chairman of the board of directors of Kernel Group Holdings Inc. and Semper Paratus Acquisition Corporation, a special purpose acquisition company. Beginning in 2021, Mr. Ajjarapu served as Chief Executive Officer and Chairman of Aesther Healthcare Acquisition Corp., a special purpose acquisition company that consummated its initial business combination in February 2023. Mr. Ajjarapu is currently serving as a director of the merged company, Ocean Biomedical Inc. Since March 2018, Mr. Ajjarapu has served as Executive Chairman of the Board of Kano Energy Corp., a company involved in the development of renewable natural gas sites in the United States. Mr. Ajjarapu was a Founder and served as Chief Executive Officer and Chairman of the Board of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest of the United States, from March 2009 to December 2012. Mr. Ajjarapu was also a Founder, President and Director of Aemetis Inc. and a Founder, Chairman and Chief Executive Officer of International Biofuels, a subsidiary of Aemetis Inc., from January 2006 to March 2009. Mr. Ajjarapu was Co-Founder, Chief Operations Officer, and Director of Global Information Technology Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India. Mr. Ajjarapu graduated from South Dakota State University with a M.S. in Environmental Engineering, and from the University of South Florida with an M.B.A., specializing in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University. Michael Peterson (age: 61) commenced serving as President, Chief Executive Officer and as a member of the Board of Directors of Lafayette Energy Corp. in April 2022. Beginning in September 2021, Mr. Peterson served as a member of the Board of Directors, Audit Committee (Chair), Compensation Committee and Nominating and Corporate Governance Committee of Aesther Healthcare Acquisition Corp. Mr. Peterson is currently serving as a director of the merged company, Ocean Biomedical Inc. In addition, Mr. Peterson commenced serving as an independent director of Oceantech Acquisition I Corp., in March 2023, began serving as an independent director of KRNL in December 2022 and as an independent director of Semper Paratus Acquisition Corporation in June 2023. Mr. Peterson has served as the president of Nevo Motors Inc. since December 2020, which was established to commercialize a range extender generator technology for the heavy-duty electric vehicle market but is currently non-operational. Since May 2022, Mr. Peterson has served as a member of the Board of Directors and as the Chairperson of the Audit Committee of Trio Petroleum Corp., an oil and gas exploration and development company which is in the process of going public. Since February 2021, Mr. Peterson has served on the board of directors and as the Chairman of the Audit Committee of Indonesia Energy Corporation Limited (NYSE American: INDO). Mr. Peterson previously served as the president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan from June 2018 to June 2021. Mr. Peterson served as an independent member of the Board of Directors of TRxADE HEALTH, INC from August 2016 to May 2021. Mr. Peterson served as the Chief Executive Officer of PEDEVCO Corp.Mr. Peterson served as Chief Financial Officer of PEDEVCO between July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (PEDEVCO's predecessor) from July 2012 to October 2014, and as PEDEVCO's President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a director (from May 2006 to July 2012) of Aemetis Inc. and as Chairman and Chief Executive Officer of Nevo Energy Inc. From 2005 to 2006, Mr. Peterson served as a managing partner of American Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high-net-worth investors. From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs & Co. in a variety of positions and roles, including as a Vice President. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham Young University.
お知らせ • May 20PowerUp Acquisition Corp. Appoints Kyle Campbell, as Class Iii Director, Effective May 16, 2022Effective May 16, 2022, the board of directors of PowerUp Acquisition Corp. appointed Kyle Campbell, as a Class III director of the Company. In connection with his appointment to the Board, Mr. Campbell has been appointed to the Audit Committee of the Board. Since May 2021, Mr. Campbell has served as a senior analyst at Greenhaven Road Capital.
Seeking Alpha • Apr 22PowerUp Acquisition Purses Video Gaming And Metaverse TargetsPowerUp Acquisition went public recently, garnering approximately $288 million in an IPO. The SPAC seeks to merge with a target in the video gaming and related industries. While management's video gaming background is impressive, they lack a SPAC track record, so I'm on Hold for PWUP in the near term.